• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Transplantation . Outcomes of Coronavirus Infectious Disease -19 (COVID-19) in Solid Organ Transplant Recipients: A Propensity Matched Analysis of a

tetano

Editor, Senior Moderator
Transplantation


. 2021 Feb 5.
doi: 10.1097/TP.0000000000003670. Online ahead of print.
Outcomes of Coronavirus Infectious Disease -19 (COVID-19) in Solid Organ Transplant Recipients: A Propensity Matched Analysis of a Large Research Network


Yousaf B Hadi[SUP] 1 [/SUP], Syeda Fz Naqvi, Justin T Kupec, Sarah Sofka, Arif Sarwari



Affiliations

Abstract

Background: Organ transplant recipients comprise an immunocompromised and vulnerable cohort. Outcomes of COVID-19 in solid organ transplant (SOT) recipients remain understudied.
Methods: We used a multicenter federated research network to compare clinical outcomes of COVID-19 in patients with SOT to a propensity matched cohort of patients without SOT.
Results: We identified 2,307 SOT recipients and 231,047 non-transplant patients with COVID-19. Transplant patients were more likely to be male, older, have a BMI >30kg/m2, and have comorbid hypertension, diabetes, nicotine dependence, heart failure and ischemic heart disease compared to non-transplant group (p-value <0.05). 1:1 matching was performed for diabetes, hypertension, chronic lung diseases, race, nicotine dependence, heart failure, ischemic heart disease and gender. There was no difference in the composite outcome of intubation or mechanical ventilation at 30 days (RR 1.04, 95% CI: 0.86-1.26) or 60 days (RR 1.03, 95% CI: 0.86-1.24) between the two groups. Hospitalization rate was higher in the transplant cohort (30.97% vs 25.47%, RR 1.22, 95% CI: 1.11-1.34). There was no difference in mortality at 30 days (6.45% vs 5.29%, RR 1.22, 95% CI: 0.88-1.68) or 60 days post diagnosis (RR 1.05, 95% CI: 0.83-1.32). More patients in the SOT group developed acute renal injury compared to non-SOT cohort (24.73% vs 14.29%; RR 1.73, 95% CI: 1.53-1.96).
Conclusion: Patients with SOT have high COVID-19 related mortality, however propensity matched analyses reveal that this increased risk is secondary to higher burden of comorbidities. SOT status independently increases risk of hospital admission and acute kidney injury.
 
Back
Top Bottom